Overview

A Study to Evaluate Add on Effect of Solifenacin in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 Weeks

Status:
Completed

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the rate of "add-on" solifenacin treatment and its persistency in men with over active bladder symptoms after tamsulosin monotherapy for 4 weeks.

Phase:

Phase 4

Details

Lead Sponsor:

KYU-SUNG LEE

Collaborator:

Astellas Pharma Korea, Inc.

Treatments:

Solifenacin Succinate
Tamsulosin